Navigation Links
Simbionix Releases Two New Platforms at the Upcoming DDW and AUA Events
Date:5/17/2012

CLEVELAND, Ohio, May 17, 2012 /PRNewswire/ --

Simbionix USA Corporation, the world's leading provider of medical simulation, training and education products, is proud to announce the release two new platform designs this week: the new GI Mentor™ Express simulator and the enhanced hardware for the URO Mentor™.

     (Logo: http://photos.prnewswire.com/prnh/20120502/529202-a)


     (Photo: http://photos.prnewswire.com/prnh/20120517/533112 )

The GI Mentor Express is an elegant portable platform offering the most advanced hands-on training in Gastrointestinal Endoscopy. This high end virtual reality trainer offers over 60 tasks and virtual patient cases for endoscopy skill enhancement, colonoscopy, gastroscopy, sigmoidoscopy and gastric bleeding. Just as in the full sized GI Mentor, training on this portable solution is done utilizing an actual scope, realistic tactile sensation and true to life anatomy, physiology and pathologies. All of the mentioned features, together with performance metrics validated in more than 40 studies, contribute to preparing the trainee for performing actual cases on live patients. The GI Mentor Express is offered in several configurations for enhanced flexible pricing. Simbionix will unveil the new GI Express at the DDW in San Diego, CA, May 20-22, booth #3025.

The newly enhanced URO Mentor being launched this week by the company was designed to enable future simulation content on the same platform. Currently the system combines training for both endourology and percutaneous access procedures. The unique cost effective design utilizes the latest technology, and is ready to be upgraded with female urologic anatomy, for future modules and training procedures. The new system will be unveiled at the upcoming AUA in Atlanta, GA, May 19-22, at booth #2761.

Ran Bronstein, Simbionix President and COO, commented that "Simbionix continues to enhance existing products and develop new products in order to provide the best value for our clients. Work on a specific trainer is on-going even after the simulator is released, as we keep on developing new modules and working on the existing configurations and platforms to improve the products and keep them updated with the latest technologies."

About Simbionix USA Corporation

Simbionix is the world's leading provider of medical simulation training and education products for medical professionals and the healthcare industry. The company is committed to delivering high quality products, advancing clinical performance and optimizing procedural outcomes.

Visit: http://www.simbionix.com  

Follow us on Facebook, Twitter and LinkedIn.

Contact: Rebecca Levy, Manager of Marketing Communications, rebecca@simbionix.com; +1-216-229-2070 #128



'/>"/>
SOURCE Simbionix USA Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Simbionix and Johnson & Johnson LLC Announce Distribution Agreement at Russia and the CIS Countries
2. Simbionix Introduces the Next Generation in Bronchoscopy Training
3. Simbionix Welcomes Two New Members to Expand Compays Medical Education Product Offerings
4. Simbionix and USF Receive Grant to Support Development of Laparoscopic Hysterectomy Simulation
5. Simbionix and AABIP Sign Collaboration Agreement
6. McGraw-Hill Professional and Simbionix™ Partner to Provide Enhanced Surgical Simulation and Education
7. Patent Granted for Simbionix Procedure Rehearsal Studio™
8. Simbionix to Introduce Three New Womens Health Products
9. Simbionix Comprehensive Medical Simulators now Available in Additional Languages
10. FDA Cleared New Application for Simbionix PROcedure Rehearsal Studio
11. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... , Feb. 23, 2017 ... clinical-stage oncology drug development company, announces that it ... Drug Administration (FDA) authorizing the initiation a Phase ... treatment for pancreatic cancer. MVT-1075 ( 177 Lu-CHX-A?-DTPA-HuMab5B1) ... (RIT). MabVax plans to initiate the phase I ...
(Date:2/23/2017)... VANCOUVER, British Columbia , Feb. 23, ... ) today announced its year end 2016 financial results.  ... January 2017, OncoGenex, and Achieve Life Science, Inc., a privately ... into a definitive merger agreement under which OncoGenex will ... the proposed merger, Achieve,s stockholders are expected to own ...
(Date:2/23/2017)... 2017 This report analyzes analyzes the worldwide markets for ... comprehensive analytics for the US, Canada , ... Asia-Pacific , Latin America ... provided for the period 2015 through 2022. Also, a six-year ... analytics are derived from primary and secondary research. Company profiles ...
Breaking Medicine Technology:
(Date:2/23/2017)... ... February 23, 2017 , ... On April 13, ... symposium on “Doping in Sport: How the Culture Might Change,” in ... LLP. The symposium will be held at Pepperdine University in Malibu, California. , ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... and community for those in the fight against cancer, has produced a seminal ... success. HRA will release top-line findings in a webinar, Defining Compassionate Care ...
(Date:2/23/2017)... RYE, New York (PRWEB) , ... February 23, 2017 , ... ... to evaluate the safety and efficacy of CM-AT in children aged 3-8 with Autism, ... the 30 clinical sites already enrolling children across the United States. , “There ...
(Date:2/22/2017)... ... February 22, 2017 , ... Our high-octane ... overwork even the sharpest brain. , Power On, a mental performance enhancer from ... clocking the brain. Each capsule contains Cognizin® Citicoline, a branded form of the ...
(Date:2/22/2017)... ... ... The National Academy of Certified Care Managers (NACCM) has ... period. NACCM, a nonprofit organization, has provided the premier certification for Care Managers ... to ensure that newly certified professionals are prepared to work effectively on behalf ...
Breaking Medicine News(10 mins):